🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the makers of Tylenol, alleging the corporations hid potential risks that the medication posed to children's brain development.

The lawsuit arrives thirty days after Former President Trump advocated an unproven link between using acetaminophen - referred to as paracetamol - throughout gestation and autism in children.

The attorney general is taking legal action against the pharmaceutical giant, which formerly manufactured the drug, the sole analgesic recommended for expectant mothers, and the current manufacturer, which now manufacturers it.

In a statement, he said they "misled consumers by gaining financially from discomfort and promoting medication ignoring the potential hazards."

The company says there is insufficient reliable data connecting acetaminophen to autism.

"These corporations deceived for years, knowingly endangering numerous people to line their pockets," Paxton, from the Republican party, stated.

The company stated officially that it was "seriously troubled by the perpetuation of misinformation on the security of paracetamol and the likely effects that could have on the health of American women and children."

On its online platform, Kenvue also stated it had "regularly reviewed the applicable studies and there is no credible data that indicates a proven link between using paracetamol and autism spectrum disorder."

Organizations speaking for physicians and medical practitioners concur.

ACOG has stated paracetamol - the primary component in Tylenol - is among limited choices for women during pregnancy to address discomfort and elevated temperature, which can present significant medical dangers if not addressed.

"In more than two decades of studies on the consumption of acetaminophen in pregnancy, zero credible investigations has definitively established that the use of paracetamol in any stage of pregnancy causes brain development issues in offspring," the organization stated.

This legal action mentions latest statements from the Trump administration in asserting the drug is allegedly unsafe.

Last month, the former president raised alarms from medical authorities when he instructed expectant mothers to "struggle intensely" not to use Tylenol when ill.

Federal regulators then issued a notice that physicians should consider limiting the consumption of acetaminophen, while also stating that "a direct connection" between the drug and autism in children has remains unverified.

Health Secretary RFK Jr, who supervises the FDA, had promised in spring to conduct "a massive testing and research effort" that would identify the source of autism in a short period.

But specialists warned that discovering a sole reason of autism spectrum disorder - thought by researchers to be the result of a complex mix of inherited and surrounding conditions - would not be simple.

Autism is a form of enduring cognitive variation and condition that affects how persons experience and interact with the environment, and is recognized using physician assessments.

In his legal document, the attorney general - who supports Trump who is running for US Senate - alleges Kenvue and J&J "willfully ignored and sought to suppress the research" around acetaminophen and autism.

The lawsuit aims to force the companies "destroy any marketing or advertising" that states acetaminophen is secure for expectant mothers.

This legal action echoes the complaints of a collection of parents of children with autism spectrum disorder and ADHD who took legal action against the makers of acetaminophen in recently.

A federal judge dismissed the legal action, declaring studies from the parents' expert witnesses was lacking definitive proof.